Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-98-001052
Filing Date
1998-02-11
Accepted
1998-02-11 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G -2-14-98 - SEQUANA THERAPEUTICS INCORPORATED SC 13G/A 6652
  Complete submission text file 0000315066-98-001052.txt   8553
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR CORP (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 161144965 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address 11099 NORTH TORREY PINES RD SUITE 160 LA JOLLA CA 92037 6194526550
SEQUANA THERAPEUTICS INC (Subject) CIK: 0000946736 (see all company filings)

EIN.: 330550509 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49547 | Film No.: 98530902
SIC: 2835 In Vitro & In Vivo Diagnostic Substances